openPR Logo
Press release

Dry Eye Syndrome Treatment Market is predicted to expand robustly at 6.4% CAGR during 2017-2027

12-21-2021 11:20 AM CET | Health & Medicine

Press release from: Future Market Insights

Common forms of artificial tears are known for being quick-fix remedies to dry eye syndrome. Drops of artificial tears with CMC and HPMC formulations were a top-selling product in the global market for dry eye syndrome treatment. Now, new products formulated from derivations of hyaluronic acid are witnessing a soaring demand among dry eye syndrome patients from around the world. Future Market Insights’ latest study on the global dry eye syndrome treatment market predicts that developing products with hyaluronic acid formulations will be observed lucrative for the market’s overall expansion.

According to the study, the global market for dry eye syndrome treatment is anticipated to bring in over US$ 4,500 Mn revenues by the end of 2017. Growing preference of consumers towards preservative-free, single dose remedies on dry eye syndrome is expected to stimulate the market’s growth. The market is also expected to witness promising support from governments & private organisations through awareness campaigns and other initiatives in the field of ophthalmic care. Towards the end of 2027, the global market for dry eye syndrome treatment is predicted to expand robustly at 6.4% CAGR, roughly doubling the 2017 value estimations by reaching US$ 6,609.3 Mn.

To remain ‘ahead’ of your competitors, request for a sample - https://www.futuremarketinsights.com/reports/sample/REP-GB-1215

Dry Eye Syndrome Treatment Market – Key Trends

Public service programs in developed economies such as the US are providing eye care through volunteering ophthalmologists. These service are free of costs, successfully drawing attention of masses. Participation of government health authorities in such eye care drives is expected to promote the market’s growth. Reduced average length of stay (AVLOS) of dry eye syndrome treatment is also driving their demand among ophthalmology labs. Increasing demand for preservative-free eye care products, harmonised data collection, and availability of advanced labs to treat dry syndrome are also observed as key trends in the global dry eye syndrome treatment market.

Forecast Highlights & Key Players

The report has profiled key players in the global market for dry eye syndrome treatment. A competitive landscape on global dry eye syndrome treatment market includes companies such as Allergan Plc., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Shire Plc., Santen Pharmaceutical Co Ltd., Valent Pharmaceuticals, Akorn, Inc., Abbott Laboratories, Thea Pharmaceuticals Limited, OASIS Medical, Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd., Reckitt Benckiser Group PLC., Medicom Healthcare Ltd., FDC Limited, Lupin Limited, Jamjoom Pharmaceuticals Co., and Sentiss Pharma Private limited.

For critical insights, request for PDF Brochure - https://www.futuremarketinsights.com/reports/brochure/rep-gb-1215

Key highlights of the report include:

- North America and Western Europe will collectively dominate the market throughout the forecast period, however, the individual revenue share will incur a marginal decline towards the latter half of the forecast period

- Due to rising pollution levels and proximity of industrial contamination, the demand for dry eye syndrome treatment will surge significantly in Asia-Pacific excluding Japan region, reflecting fastest value growth at a CAGR of 7.4%

- In 2017 and beyond, cyclosporine will be observed as top-selling product on dry eye syndrome treatment, global sales of which will account for a vigorous revenue growth at 6.9% CAGR

- More than 60% of global dry eye syndrome treatment market will be dominated by sales through retail pharmacies, making them the largest distribution channel in the market.

Read Full Report - https://www.futuremarketinsights.com/reports/dry-eye-syndrome-treatment-market

Contact Us:

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dry Eye Syndrome Treatment Market is predicted to expand robustly at 6.4% CAGR during 2017-2027 here

News-ID: 2506439 • Views:

More Releases from Future Market Insights

Tumor Profiling Market Size and Share Forecast Outlook From 2025 to 2035
Tumor Profiling Market Size and Share Forecast Outlook From 2025 to 2035
The Tumor Profiling Market is entering a transformative decade, driven by precision oncology, liquid biopsy advancements, advanced sequencing technologies, and growing demand for personalized cancer treatment. As leading companies like Thermo Fisher Scientific, Illumina, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, and Agilent Technologies strengthen their product portfolios, the tumor profiling market is expected to witness sustained adoption across diagnostic laboratories, clinics, and hospitals. "Explore trends before investing - request a sample
Personalization Lead the Prescription Lens Market Share Analysis Growth Path
Personalization Lead the Prescription Lens Market Share Analysis Growth Path
The global Prescription Lens Market Share Analysis is entering a pivotal growth phase as aging populations, digital lifestyles, and advanced vision-care technologies reshape consumer needs. The market is projected to grow at a 3.7% CAGR and reach USD 62,666.2 million by 2035. As demand continues accelerating, leading brands are refining their strategies to serve evolving optical expectations. "Explore trends before investing - request a sample report today!" https://www.futuremarketinsights.com/reports/sample/rep-gb-20711 Market Momentum: What Is Powering
Peptide Microarray Market Growth Outlook to 2035: Innovation, Strategy, and Market Impact
Peptide Microarray Market Growth Outlook to 2035: Innovation, Strategy, and Mark …
The Peptide Microarray Market is entering a transformative phase driven by technology advancements, rising investment in proteomics, and expanding applications across diagnostics and drug discovery. According to projections, the peptide microarray market is set to reach USD 903.8 million by 2025, progressing steadily at a CAGR of 3.8% through 2035. Precision tools, proteomics infrastructure growth, and innovation in peptide profiling platforms continue to reshape the future of global healthcare innovation. Explore
Japan Cold Laser Therapy Market Size and Share Forecast Outlook From 2025 to 2035
Japan Cold Laser Therapy Market Size and Share Forecast Outlook From 2025 to 203 …
The Japan Cold Laser Therapy Market is set for steady expansion as healthcare providers, manufacturers, and end users shift toward advanced non-invasive treatment technologies. The (Japan Cold Laser Therapy Market) is projected to rise from USD 7.2 million in 2025 to USD 12.0 million by 2035, reflecting a CAGR of 5.2%. Cold laser therapy is gaining recognition due to its ability to reduce inflammation, promote healing, and alleviate pain-without requiring

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the